Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

T. Roe, Matthew; W. Armstrong, Paul; A.A. Fox, Keith; D. White, Harvey; Prabhakaran, Dorairaj; G. Goodman, Shaun; H. Cornel, Jan; L. Bhatt, Deepak; Clemmensen, Peter; A. Martínez, Felipe; Ardissino, Diego; Carlos Nicolau, José; E. Boden, William; A. Gurbel, Paul; Rużyłło, Witold; J. Dalby, Anthony; K. McGuire, Darren; L. Leiva-Pons, José; Parkhomenko, Alexander; Gottlieb, Shmuel; O. Topacio, Gracita; W. Hamm, Christian; Pavlides, Gregory; Goudev, Assen; Oto, Ali̇; Tseng, Chuen‐Den; Merkely, Béla; Gašparović, Vladimir; Corbalán, Ramón; Cintezǎ, Mircea; Craig McLendon, R.; J. Winters, Kenneth; B. Brown, Eileen; Lokhnygina, Yuliya; E. Aylward, Philip; Huber, Kurt; S. Hochman, Judith; Magnus Ohman, E.

doi:10.1056/nejmoa1205512

Public

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

Published in New England Journal of Medicine • Aug 26, 2012

Authors:

Matthew T. Roe

Paul W. Armstrong

Keith A.A. Fox

Abstract

BACKGROUND: The effect of intensified platelet inhibition for patients with unstable angina or myocardial infarction without ST-segment elevation who do not undergo revascularization has not been delineated. METHODS: In this double-blind, randomized trial, in a primary analysis involving 7243 patien...

Subject

Prasugrel

Clopidogrel

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!